ISMPP Podcast 2022: InformEDISMPP talks about key trends and issues facing medical communication and publication professionals in an ever-evolving field. Subscribe to this podcast where you can hear experts share their thought-provoking insights and lessons! Episode 4: Posting with a Purpose: Using social media to reach your audience: Part 2
Episode 3: Posting with a Purpose: Using social media to reach your audience: Part 1 The Nuts and Bolts
Episode 2: Privacy Matters: Protecting Data Amid Evolving Laws and TechnologyData privacy is not always a fun topic, but our podcast guest is another fantastic speaker from the Annual Meeting and is enthusiastic and knowledgeable! In this episode, we discuss the implications of international and domestic privacy laws and how they specifically impact medical publications professionals. Of particular importance to our industry is patient privacy in clinical trials and the challenges in protecting their identities. Jordan Fischer leads the Octillo Legal & Tech Global Data Privacy Team and focuses her practice on international data privacy and cybersecurity and cross-border data management, with an emphasis in European Union data privacy regulations and GDPR. She’s a Lecturer in Cybersecurity at the University of California, Berkeley and a Professor of Law at the Drexel University Thomas R. Kline School of Law. She is also the Director of the Kline School of Law’s Center for Law and Transformational Technology. Jordan is an active speaker, presenter and published expert in data privacy, technology compliance and cybersecurity. Generously sponsored by MedThink SciCom. Decentralized Trials & Impact on Medical PublicationsEpisode 1: Bringing It Home: Next Generation of Clinical Trails & Implications for Publication ProfessionalsThe COVID pandemic both accelerated adoption of decentralized clinical trials and highlighted the importance of decentralization in making clinical trials more patient-centric. These trials allow for the continuation of research in challenging periods, as we have seen recently with the global pandemic and in times of war. They don’t, however need to be viewed as only a fall-back methodology as there are numerous benefits that make decentralized trials a methodological option and not just an alternative. They have the potential to improve patient engagement in research and certainly help with equity, diversity and inclusion. Join us for a conversation about decentralized trials with Craig Lipset. Craig is the Co-founder and Co-chair of the Decentralized Trials & Research Alliance which is the industry's largest non-profit collaboration exclusively focused on the global adoption of decentralized research; he is also a board Vice Chair for MedStar Health Research Institute and Vice President of the Foundation for Sarcoidosis Research. Generously sponsored by MedThink SciCom. All podcasts are generously sponsored by MedThink SciCom |